Pegylated interferon α therapy in acute hepatitis C: Relation to hepatitis C virus–specific T cell response kinetics von Kamal, Sanaa M., Ismail, Alaa, Graham, Camilla S., He, Qi, Rasenack, Jens W., Peters, Thomas, Tawil, Ahmed A., Fehr, Jutta J., Khalifa, Khalifa El Sayed, Madwar, Mahmoud M., Koziel, Margaret James

Volltext

Duration of peginterferon therapy in acute hepatitis C : A randomized trial von KAMAL, Sanaa M, MOUSTAFA, Khairy N, AFDHAL, Nezam H, CHEN, Jason, FEHR, Jutta, MONEIM, Azza Abdel, KHALIFA, Khalifa E, EL GOHARY, Leila A, RAMY, Amr H, MADWAR, Mohamed A, RASENACK, Jens

Volltext

Abstract LB-B05: Characterization of a panel of 79 PDX-derived cell lines with a focus on the EGFR exon 20 insertion mutation-driven NSCLC model LXFE 2478 von Kelter, Gerhard, Peille, Anne-Lise, Fehr, Jutta, Klett, Hagen, Maier, Armin, Posch, Markus, Metz, Thomas M

Volltext

Peginterferon alone or with ribavirin enhances HCV-specific CD4+ T-helper 1 responses in patients with chronic hepatitis C von Kamal, Sanaa M., Fehr, Jutta, Roesler, Bernd, Peters, Thomas, Rasenack, Jens W.

Volltext

63 Peginteferon α-2A (40KD) enhances HCV specific T-cell responses by restoration of allostimulatory function of dendritic cells in chronic hepatitis C von Kamal, Sanaa M., He, Qi, Fehr, Jutta, Ismail, Alaa M., Roessler, Bernd, Massoud, Mahmoud A., Rasenack, Jens

Volltext